PepGen News - PEPG

Company Name	Stock Ticker Symbol	Market	Type
PepGen Inc	PEPG	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.59	4.24%	14.49	16:00:49

Open Price	Low Price	High Price	Close Price	Prev Close
14.00	13.41	14.59	14.49	13.90

more quote information »

Recent News

Date	Time	Source	Heading
5/02/2024	10:07	IHNW	FeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
3/13/2024	16:05	GLOBE	PepGen to Participate in Upcoming Investor Conferences
3/13/2024	07:00	GLOBE	PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric..
3/06/2024	16:23	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/06/2024	16:01	GLOBE	PepGen Reports Fourth Quarter and Full Year 2023 Financial..
3/06/2024	16:00	EDGAR2	Form 8-K - Current report
3/04/2024	07:27	EDGAR2	Form 8-K - Current report
3/04/2024	07:00	GLOBE	PepGen Announces Clearance of CTA by UK Medicines &..
3/01/2024	17:49	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/01/2024	17:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/01/2024	17:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/20/2024	08:00	EDGAR2	Form 8-K - Current report
2/20/2024	08:00	GLOBE	PepGen Receives U.S. FDA Fast Track Designation for..
2/07/2024	16:55	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2/07/2024	07:36	EDGAR2	Form 8-K - Current report
2/07/2024	07:30	GLOBE	PepGen Announces Pricing of $80.1 Million Underwritten..
1/17/2024	08:00	EDGAR2	Form 8-K - Current report
1/17/2024	07:00	GLOBE	Mary Beth DeLena Joins PepGen as General Counsel and..
1/08/2024	07:00	EDGAR2	Form 8-K - Current report
1/08/2024	07:00	GLOBE	PepGen Announces First Patient Dosed in CONNECT1-EDO51 Phase..
12/18/2023	08:00	EDGAR2	Form 8-K - Current report
12/18/2023	08:00	GLOBE	PepGen Announces First Patient Dosed in Phase 1 FREEDOM-DM1..
11/15/2023	08:00	EDGAR2	Form 8-K - Current report
11/15/2023	08:00	GLOBE	PepGen Announces Appointment of Howard Mayer, M.D. to Board..
11/08/2023	08:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/2023	08:00	EDGAR2	Form 8-K - Current report
11/08/2023	08:00	GLOBE	PepGen Reports Third Quarter 2023 Financial Results and..
10/12/2023	07:52	DJN	FDA Lifts Hold on PepGen's New Drug Application for..
10/12/2023	07:05	EDGAR2	Form 8-K - Current report
10/12/2023	07:00	GLOBE	PepGen Inc. Announces FDA has Lifted the Clinical Hold on..
9/27/2023	16:16	GLOBE	PepGen Announces Upcoming Presentations at the 28th Annual..
9/06/2023	16:06	EDGAR2	Form 8-K - Current report
9/06/2023	16:05	GLOBE	PepGen Inc. Announces Clearance of CTA by Health Canada to..
9/06/2023	08:16	EDGAR2	Form 8-K - Current report
9/06/2023	08:00	GLOBE	PepGen Inc. Presents PGN-EDODM1 Preclinical Data Supporting..
9/01/2023	08:00	GLOBE	PepGen Announces Presentations at the 2023 Myotonic..
8/08/2023	08:49	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
8/08/2023	08:27	EDGAR2	Form 8-K - Current report
8/08/2023	08:17	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	08:15	EDGAR2	Form 8-K - Current report
8/08/2023	08:15	GLOBE	PepGen Reports Second Quarter 2023 Financial Results and..
6/13/2023	17:07	DJN	PepGen Withdraws Guidance on Launch of Study for Muscle..
6/13/2023	16:05	GLOBE	PepGen Inc. Provides Update on Planned Initiation of Phase 1..
5/30/2023	17:24	DJN	PepGen Shares Tumble 18.4% After FDA Issues Hold Notice on..
5/30/2023	16:05	GLOBE	PepGen Inc. Announces Clinical Hold in the U.S. on IND..
5/18/2023	07:00	GLOBE	PepGen Announces Clearance by Health Canada of CTA for..
5/11/2023	07:00	GLOBE	PepGen Reports First Quarter 2023 Financial Results and..
5/04/2023	08:00	GLOBE	PepGen to Participate in the Bank of America Securities 2023..